Empowering Tomorrow’s Fertility Care
Explore new insights into fertility research, clinic performance metrics, and notable developments shaping the field of reproductive health.
.jpg)
.jpeg)
Supporting Embryo Health Assessment
01
Non-Invasive
Technology
Listens to biological signals released by embryos without being invasive.
02
Seamless Integration
Easily integrates with clinic workflows for efficient use.
03
Patient-Centered Insights
Empowers patients with clear, actionable health data.
04
Data-Driven
Support
Provides clinicians with deep insights to guide decisions.
Complementing Fertility Assessments with Peptivue
Find quick and clear answers to your pressing fertility-related questions, empowering informed decisions.
How does Peptivue support embryo health assessment?
Peptivue provides
non-invasive insights into embryo health, ensuring a higher level of precision for clinicians.
Is Peptivue compatible with existing fertility
clinic processes?
Yes, Peptivue seamlessly integrates into current
workflows, offering innovation without disruption.
What makes Peptivue different from traditional methods?
Peptivue delivers cutting-edge, non-invasive technology that provides insights and focus on signal detection.
Who can benefit from using Peptivue’s solutions?
Both fertility clinicians and patients benefit through improved diagnostics and personalized care.
Strength that speaks
for itself
Explore our tailored pricing options, designed to bring innovative
fertility solutions within reach.
Reproducibility &
Scalability
Built to support future growth and broader adoption.
Patient
Empowerment Tools
Empowering patients with insights that foster confidence and informed decisions.
Seamless
Integration
Easily incorporates into clinic workflows, enhancing efficiency and innovation.
Peptivue
Solutions
Invest in Us
PeptiVue is a bio-enabled sensing and analytics company developing a non-invasive platform for embryo assessment in IVF. By detecting naturally occurring peptide signals in culture media and translating them into actionable insights. PeptiVue adds a biological signal layer to existing embryo evaluation approaches.
Supported by early pilot validation, research collaborations, and non-dilutive funding, PeptiVue is preparing for a Series A investment to scale platform development, expand validation, and accelerate commercialization.
We welcome conversations with investors and strategic partners aligned with the future of reproductive health technology.
Contact us to learn more about how you can invest in the future of reproductive health.
Get in Touch
Contact Us to Learn More